BOEHRINGER INGELHEIM
Boehringer Ingelheim is a research-driven group of companies dedicated to researching, developing, manufacturing, and marketing pharmaceuticals that improve health and quality of life. Our businesses comprise Prescription Medicine, Animal Health, and Biopharmaceuticals.
BOEHRINGER INGELHEIM
Industry:
Biotechnology Medical Pharmaceutical
Founded:
1885-01-01
Address:
Ingelheim Am Rhein, Rheinland-Pfalz, Germany
Country:
Germany
Website Url:
http://www.boehringer-ingelheim.com
Total Employee:
10001+
Status:
Active
Contact:
+49 - 6132 - 770
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Font Awesome Domain Not Resolving Wordpress Plugins
Similar Organizations
AOP Orphan Pharmaceuticals
AOP Orphan Pharmaceuticals engages in developing, marketing, and distributing medicines for orphan indications and complex diseases.
Avacta Animal Health
Avacta Animal Health is an veterinary laboratory service provider and diagnostic tester to surgeons, laboratories on animal allergies.
Boehringer Mannheim
Boehringer Mannheim is a Germany-based maker of drugs and diagnostic products.
Mayne Pharma
Mayne Pharma Group, a specialist pharmaceutical company, optimizes and delivers oral drugs.
Novo Nordisk
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care.
Current Advisors List
Board_member
Board_member
Board_member
Board_member
Board_member
Current Employees Featured
Christian Eckermann SVP, Head of Biopharma Austria @ Boehringer Ingelheim
SVP, Head of Biopharma Austria
2016-07-01
Rainer Kirch Head of Dept. Logistics, Foreign Trade and Mobility @ Boehringer Ingelheim
Head of Dept. Logistics, Foreign Trade and Mobility
2013-01-01
Melanie Ruppel Head of Global Submission Services Ingelheim @ Boehringer Ingelheim
Head of Global Submission Services Ingelheim
Jan Cassen Kraus Head of Supply Chain Management @ Boehringer Ingelheim
Head of Supply Chain Management
2016-01-01
Arun Thachi Director, IT Omnichannel Ecosystem Evolution @ Boehringer Ingelheim
Director, IT Omnichannel Ecosystem Evolution
2022-04-01
Klaus-Peter Kammerer Global Clinical Program Leader @ Boehringer Ingelheim
Global Clinical Program Leader
2021-05-01
Clive Wood Senior Vice President @ Boehringer Ingelheim
Senior Vice President
2014-03-01
Victoria Gamerman Global Head of Data Governance and Insights @ Boehringer Ingelheim
Global Head of Data Governance and Insights
2021-07-01
Anjan Chatterjee Corporate Vice President @ Boehringer Ingelheim
Corporate Vice President
2018-02-01
Joseph Scherer Sr Associate Director @ Boehringer Ingelheim
Sr Associate Director
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-06-15 | Trutino Biosciences | Trutino Biosciences acquired by Boehringer Ingelheim | N/A |
| 2021-09-21 | Abexxa Biologics | Abexxa Biologics acquired by Boehringer Ingelheim | N/A |
| 2020-12-10 | NBE-Therapeutics | NBE-Therapeutics acquired by Boehringer Ingelheim | 1.18 B EUR |
| 2020-12-09 | Labor Dr. Merk & Kollegen | Labor Dr. Merk & Kollegen acquired by Boehringer Ingelheim | N/A |
| 2020-07-27 | Global Stem cell Technology | Global Stem cell Technology acquired by Boehringer Ingelheim | N/A |
| 2020-05-14 | Northern Biologics Inc. | Northern Biologics Inc. acquired by Boehringer Ingelheim | N/A |
| 2019-07-15 | Amal Therapeutics | Amal Therapeutics acquired by Boehringer Ingelheim | 325 M EUR |
| 2019-03-29 | ICD Therapeutics | ICD Therapeutics acquired by Boehringer Ingelheim | N/A |
| 2018-09-13 | Vira Therapeutics | Vira Therapeutics acquired by Boehringer Ingelheim | 245 M USD |
| 2017-01-01 | Merial Limited | Merial Limited acquired by Boehringer Ingelheim | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-09-11 | Click Therapeutics | Boehringer Ingelheim investment in Funding Round - Click Therapeutics | 500 M USD |
| 2020-07-31 | Proxygen | Boehringer Ingelheim investment in Grant - Proxygen | N/A |
| 2020-01-10 | NBE-Therapeutics | Boehringer Ingelheim investment in Series C - NBE-Therapeutics | 22 M USD |
| 2018-07-09 | MabVax Therapeutics | Boehringer Ingelheim investment in Post-IPO Equity - MabVax Therapeutics | 11 M USD |
| 2018-01-01 | Greybox Solutions | Boehringer Ingelheim investment in Series A - Greybox Solutions | N/A |
| 2014-11-25 | Promethera Biosciences | Boehringer Ingelheim investment in Series C - Promethera Biosciences | 25.3 M EUR |
Newest Events participated
Official Site Inspections
http://www.boehringer-ingelheim.com Semrush global rank: 112.74 K Semrush visits lastest month: 847.37 K
- Host name: 45.60.248.221
- IP address: 45.60.248.221
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Boehringer Ingelheim"
Boehringer Ingelheim - Wikipedia
C.H. Boehringer Sohn AG & Co. KG is the parent company of the Boehringer Ingelheim group, which was founded in 1885 by Albert Boehringer (1861–1939) in Ingelheim am Rhein, …See details»
PAGE 10–48 GROUP MANAGEMENT REPORT - Boehringer Ingelheim
Boehringer Ingelheim - The Org
At Boehringer Ingelheim they create value through innovation with one clear goal: to improve the lives of patients. They develop breakthrough therapies and innovative healthcare solutions in areas of unmet medical need for both …See details»
Boehringer Ingelheim (Canada) Ltd. | Arthritis Society …
In 2018, Boehringer Ingelheim achieved net sales of around 17.5 billion euros. R&D expenditure of almost 3.2 billion euros, corresponded to 18.1 per cent of net sales. As a family-owned company, Boehringer Ingelheim plans in generations …See details»
Boehringer Ingelheim Org Chart + Executive Team
The organizational chart of Boehringer Ingelheim displays its 78 main executives including Hubertus von Baumbach, Frank Hübler and Jan Visser. Toggle navigation The Official Board. Search. Search. Search by segment. Sign In. …See details»
Boehringer Ingelheim: Culture - LinkedIn
Learn more about our history as a global family. We started writing our part of history some 140 years ago, with just 28 people and our founder Albert Boehringer (1861-1939).See details»
About Us | Boehringer Ingelheim CA
Boehringer Ingelheim is a global group of companies embracing many cultures and diverse societies. Learn more about the financial highlights, the corporate vision, the organization, the Board of Managing Directors, and the company's …See details»
Boehringer Ingelheim (Canada) Ltd. - Life Sciences Ontario Site
Boehringer Ingelheim is working on breakthrough therapies that improve the lives of humans and animals. As a leading research-driven biopharmaceutical company, the company creates …See details»
About us - Boehringer Ingelheim
Boehringer Ingelheim is a global group of companies embracing many cultures and diverse societies. Learn more about the financial highlights, the corporate vision and the organisation. View this SectionSee details»
Who we are - Boehringer Ingelheim
Apr 2, 2025 As a family-owned company Boehringer Ingelheim is governed by the Board of Managing Directors composed of six members. Read more about their respective responsibilities. Read more Teaming up to strengthen our …See details»
Boehringer Ingelheim - Leadership Team - The Org
The Leadership Team at Boehringer Ingelheim is responsible for steering the company towards its mission of enhancing patient care through innovative solutions. Comprising top executives …See details»
Boehringer Ingelheim Pharmaceuticals - amga.org
Boehringer Ingelheim is a research-driven group of companies dedicated to the discovery, development, manufacture and marketing of innovative health care products. We are …See details»
Geschäftsbericht 2021 - Boehringer Ingelheim
For generations, Boehringer Ingelheim has been working to improve the health of humans and animals. Sustainable development is at the heart of the company and is a journey which …See details»
Boehringer Ingelheim - Crunchbase Company Profile & Funding
Organization. Boehringer Ingelheim . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. Boehringer Ingelheim specialises in finding …See details»
Organisation - boehringer-ingelheim-stiftung.de
Located in central Mainz, the head office of the Boehringer Ingelheim Foundation conducts the daily business in accordance with the wishes of the Executive Committee, and implements its …See details»
ZEISS unveils AI-powered Research Data Platform ... - Newswire
2 days ago ZEISS's collaboration with Boehringer Ingelheim - championing data-driven, personalized care through ZEISS's ongoing research partnership with Boehringer Ingelheim; …See details»
Boehringer Ingelheim and Cue Biopharma partner to develop
Apr 14, 2025 Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry’s top investors in research and development, the …See details»
Our Story: Mission Vision | Boehringer Ingelheim US
Boehringer Ingelheim, founded in 1885 by Albert Boehringer in Ingelheim, Germany, began with just 28 people employed to manufacture tartaric acid salts. Now, more than 130 years later, …See details»
Boehringer Ingelheim - Life Forward | Boehringer Ingelheim
Boehringer Ingelheim is a research-driven group of companies dedicated to the discovery, development, manufacture and marketing of innovative health care products. Section overview …See details»
About Us | BIPI Medical & Clinical Resources - pro.boehringer …
About Boehringer Ingelheim. BI was founded in 1885 as a small, family-owned chemical company. Over the decades, our commitment to innovation and patient care has driven us to …See details»